BGPT: Author Review: Shalu Sharma

Explore by Goal

Low confidence. Please provide more context.

Quick Explanation Copied

Shalu Sharma — scientific strength (based on provided record)

Scholarly impact: OpenAlex reports ~920 total citations, h-index ~15, and ~89 works for an author profile matching “Shalu Sharma”.
Biological/medical relevance: The matched profile topics strongly emphasize Medicine/Biology/Oncology, but your provided publication list (4 items) spans multiple domains (CAR expression kinetics; robotics/ENT; partographs/nursing; beekeeping).

Primary source for these metrics: OpenAlex author record (Shalu Sharma).

Scientific caution: the name “Shalu Sharma” may refer to multiple people in scholarly databases; the OpenAlex match is probabilistic, so mismatched author attribution would change the assessment.

Long Explanation

Author Review: Shalu Sharma

Evidence scope: OpenAlex-derived author metrics + the 4 paper titles you provided (no full-text contents were supplied in your prompt).

1) Attribution & data provenance (what we can and cannot claim)

Metrics basis: The citation metrics and topic labels below come from an OpenAlex profile that matches “Shalu Sharma”.
Your provided work list: You supplied 4 titles spanning medicine/biomed and also non-biomedical domains (e.g., robotics/ENT, nursing partographs, beekeeping). With only titles, we cannot evaluate experimental rigor (methods, sample sizes, controls, statistics) or whether the work is biologically substantive without the full papers.
Therefore: This review emphasizes (i) bibliometric footprint, (ii) domain coherence risk, and (iii) concrete missing evidence needed for a true scientific-rigor assessment.

2) Scholarly impact snapshot (OpenAlex)

Works count: ~89
Cited-by count: ~920
h-index: ~15
Top inferred topics: Medicine, Biology, Internal medicine, Oncology, Cancer

Source: OpenAlex author record: Shalu Sharma .

3) Domain coherence check (from your 4 provided titles)

Titles you provided

Pharmacokinetics, Biodistribution and Anti-CD19 CAR Expression Kinetics in Vitro and after In Vivo Delivery of a CD8-Targeted Fusosome in NSG Mice
Learning Curve in Robotics in ENT and Head and Neck Surgery
Assess Knowledge and Practice Regarding Partograph among Staff Nurses: Pre experimental Study
Prospects of beekeeping in Haryana: Perceived needs, constraints and enablers

Evidence limitation: without abstracts/full text, we cannot infer whether these represent distinct research programs or database/author-disambiguation noise.

4) Scientific strength: what can be inferred vs what cannot

Known from provided data

Impact indicators exist: the OpenAlex record for a “Shalu Sharma” match reports a non-trivial bibliometric footprint (works ~89, citations ~920, h-index ~15).
Topic signals skew biomedical: OpenAlex concept/topic assignment for this profile emphasizes Medicine/Biology/Oncology/Cancer.

Not assessable from provided data (major gap)

Experimental rigor unknown: No full-text methods, sample sizes, controls, blinding/randomization, statistical tests, or reproducibility details are provided.
Attribution risk: name ambiguity can merge or split author identities, distorting bibliometrics. OpenAlex disambiguation can be imperfect for common names.
Domain spread ambiguity: the 4 titles you provided look heterogeneous; this could reflect interdisciplinary breadth, or it could reflect partial mismatched authorship across records. With only titles, we cannot decide.

5) Critical evaluation (skeptical, evidence-based)

Bibliometrics ≠ rigor: citations reflect community uptake, not necessarily methodological correctness. High citations can occur for compelling novelty, but also for survey/controversy/negative results, and bibliometric distributions are confounded by field size and time. (These are general bibliometric limitations; bibliometrics for this specific profile comes from OpenAlex.)
Publication bias & selective reporting: without the underlying study designs and statistical reporting, we cannot evaluate whether the body of work is robust against p-hacking, selective outcome reporting, or underpowered studies. This requires full-text or at least methods/results sections.
Reproducibility & raw data: your prompt requests “raw-data grounded review,” but no raw datasets or full-text extracts were provided for the cited papers. Therefore, any claim about reproducibility would be speculative.
Cross-field mismatch risk: if the author’s biomedical output is small and the name match pulls in non-biomedical works (or vice versa), the apparent biomedical “strength” may be inflated or deflated. This is especially relevant for the heterogeneous 4-title set you provided.

6) What I would need to upgrade this into a true scientific rigor review

For each biomedical paper: full-text methods (study design, endpoints), raw/processed figures/tables, n, exclusion criteria, assay/platform details, and statistical analysis plan.
Evidence of biological validation: independent replicates, orthogonal assays, and appropriate controls (vehicle, isotype/irrelevant targeting, positive controls for assay performance).
For CAR/fusosome pharmacokinetics/biodistribution: sampling schedule, biodistribution quantification method, model assumptions in the kinetics, and whether the work includes mechanistic readouts (not just expression metrics).

If you paste PDFs/links or upload full text, BGPT can extract raw experimental data and build evidence tables.

Reference (source of bibliometrics used above)

OpenAlex author record: Shalu Sharma

Note: A complete “scientific strength” assessment (experimental rigor, validity, reproducibility) requires full-text information; this response is therefore constrained to bibliometrics + the title list you provided.

Feedback:

Updated: April 18, 2026